search

Active clinical trials for "Choroidal Neovascularization"

Results 111-120 of 174

Ranibizumab Therapy for Choroidal Neovascularization (CNV) Asociated With Angioid Streaks

Angioid Streaks

The purpose of this study is to determine whether injections of ranibizumab into the eye are safe and well tolerated when given to subjects in multiple doses.

Withdrawn23 enrollment criteria

Imatinib Mesylate Combined With Intravitreal Ranibizumab in the Treatment of Choroidal Neovascularization...

Choroidal Neovascularization

The purpose of study is to determine if Lucentis combined with imatinib mesylate will help treatment in patients with newly diagnosed choroidal neovascularization.

Withdrawn27 enrollment criteria

Value of Genetic Counseling and Testing for Patients Who Would Like to Know More About Their Personal...

Age-Related Macular DegenerationChoroidal Neovascularization1 more

The goals of this study are: To assess the impact of genetic testing based on how it alters behaviors, to assess the utility of serum biomarker measurement in combination with genetic testing, to assess the utility of genetic counseling in personal analysis of risk for age-related macular degeneration (AMD), and to assess the impact of presymptomatic genetic testing for choroidal neovascularization (CNV).

Completed4 enrollment criteria

Intravitreal Pegaptanib in Treatment of Choroidal Neovascularisation Secondary to Pathologic Myopia...

Myopic Choroidal Neovascular Membrane

Intravitreal pegaptanib for treatment of choroidal neovascularisation secondary to pathologic myopia

Withdrawn18 enrollment criteria

Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMD

Choroidal NeovascularizationMyopia7 more

Anti-VEGF therapy has been proven efficacious for the wet (neovascular) form of macular degeneration and may be beneficial for the treatment of choroidal neovascularization (CNV) due to other causes. The limitation of this type of treatment is the necessity for frequent intraocular injections. The purpose of this study is to determine if using anti-VEGF therapy in combination with photodynamic therapy can reduce the number of treatments needed with monotherapy while achieving similar visual results. There are ongoing multicenter trials evaluating combination therapy in patients with wet AMD but no similar trial for patients with CNV due to non-AMD causes. Therefore, in this study the investigators will focus on patients with CNV not due to AMD.

Withdrawn26 enrollment criteria

Randomized Study for Efficacy and Safety of Ranibizumab 0.5mg in Treat-extend and Monthly Regimens...

Age-related Macular DegenerationChoroidal Neovascularization

This study was designed to evaluate the efficacy and safety of two different regimens of 0.5 mg ranibizumab given as intravitreal injection in patients with neovascular age-related macular degeneration

Completed15 enrollment criteria

Multifocal Electrophysiologic Findings After Intravitreal Bevacizumab(Avastin)Treatment

Diabetic Proliferative RetinopathyVascular Vein Oclussion1 more

Purpose: Determine the short-term safety of intravitreal bevacizumab by multifocal electroretinography (mf-ERG). Methods: 120 eyes with choroidal neovascularization, proliferative diabetic retinopathy and retinal vein occlusion received intravitreal bevacizumab (2.5mg/0.1cc). All patients underwent best corrected visual acuity, fluorescein angiography, optical coherent tomography and mf-ERG before and 1 month after treatment.

Completed6 enrollment criteria

Intravitreal Conbercept for Idiopathic Choroidal Neovascularization

Idiopathic Choroidal Neovascularization

The purpose of this study is to evaluate the efficacy of intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy as primary treatment for ICNV.

Unknown status29 enrollment criteria

Aflibercept Intravitreal Injection for Myopic Choroidal Neovascularization

Choroidal Retinal Neovascularization

The purpose of this study is to evaluate the clinical results of anti-VEGF intra-vitreal injections (IVT) in CNV secondary

Unknown status8 enrollment criteria

Efficacy of Retreatments With Intravitreal Bevacizumab

Age Related Macular DegenerationChoroidal Neovascularization

Choroidal neovascularization is a leading cause of visual loss in people older than 60 years and for its treatment there had been performed multicentric studies with Lucentis (Ranibizumab) with a significant improval of visual acuity. In our institution we evaluated efficacy of bevacizumab in several pathologies but we dont know what would be the results if we use the same dose several times. Our purpose was to determine the efficacy of bevacizumab for improve or stabilize visual acuity with two or more intravitreal inyections of bevacizumab.

Unknown status6 enrollment criteria
1...111213...18

Need Help? Contact our team!


We'll reach out to this number within 24 hrs